Cargando…
L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia
BACKGROUND: Hyperoxia is shown to impair airway relaxation via limiting L-arginine bioavailability to nitric oxide synthase (NOS) and reducing NO production as a consequence. L-arginine can also be synthesized by L-citrulline recycling. The role of L-citrulline supplementation was investigated in th...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487946/ https://www.ncbi.nlm.nih.gov/pubmed/22870905 http://dx.doi.org/10.1186/1465-9921-13-68 |
_version_ | 1782248550563840000 |
---|---|
author | Sopi, Ramadan B Zaidi, Syed IA Mladenov, Mitko Sahiti, Hazbije Istrefi, Zahide Gjorgoski, Icko Lajçi, Azem Jakupaj, Muharrem |
author_facet | Sopi, Ramadan B Zaidi, Syed IA Mladenov, Mitko Sahiti, Hazbije Istrefi, Zahide Gjorgoski, Icko Lajçi, Azem Jakupaj, Muharrem |
author_sort | Sopi, Ramadan B |
collection | PubMed |
description | BACKGROUND: Hyperoxia is shown to impair airway relaxation via limiting L-arginine bioavailability to nitric oxide synthase (NOS) and reducing NO production as a consequence. L-arginine can also be synthesized by L-citrulline recycling. The role of L-citrulline supplementation was investigated in the reversing of hyperoxia-induced impaired relaxation of rat tracheal smooth muscle (TSM). METHODS: Electrical field stimulation (EFS, 2–20 V)-induced relaxation was measured under in vitro conditions in preconstricted tracheal preparations obtained from 12 day old rat pups exposed to room air or hyperoxia (>95% oxygen) for 7 days supplemented with L-citrulline or saline (in vitro or in vivo). The role of the L-citrulline/L-arginine cycle under basal conditions was studied by incubation of preparations in the presence of argininosuccinate synthase (ASS) inhibitor [α-methyl-D, L-aspartate, 1 mM] or argininosuccinate lyase inhibitor (ASL) succinate (1 mM) and/or NOS inhibitor [N(ω)-nitro-L-arginine methyl ester; 100 μM] with respect to the presence or absence of L-citrulline (2 mM). RESULTS: Hyperoxia impaired the EFS-induced relaxation of TSM as compared to room air control (p < 0.001; 0.5 ± 0.1% at 2 V to 50.6 ± 5.7% at 20 V in hyperoxic group: 0.7 ± 0.2 at 2 V to 80.0 ± 5.6% at 20 V in room air group). Inhibition of ASS or ASL, and L-citrulline supplementation did not affect relaxation responses under basal conditions. However, inhibition of NOS significantly reduced relaxation responses (p < 0.001), which were restored to control level by L-citrulline. L-citrulline supplementation in vivo and in vitro also reversed the hyperoxia-impaired relaxation. The differences were significant (p <0.001; 0.8 ± 0.3% at 2 V to 47.1 ± 4.1% at 20 V without L-citrulline; 0.9 ± 0.3% at 2 V to 68.2 ± 4.8% at 20 V with L-citrulline). Inhibition of ASS or ASL prevented this effect of L-citrulline. CONCLUSION: The results indicate the presence of an L-citrulline/L-arginine cycle in the airways of rat pups. L-citrulline recycling does not play a major role under basal conditions in airways, but it has an important role under conditions of substrate limitations to NOS as a source of L-arginine, and L-citrulline supplementation reverses the impaired relaxation of airways under hyperoxic conditions. |
format | Online Article Text |
id | pubmed-3487946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34879462012-11-03 L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia Sopi, Ramadan B Zaidi, Syed IA Mladenov, Mitko Sahiti, Hazbije Istrefi, Zahide Gjorgoski, Icko Lajçi, Azem Jakupaj, Muharrem Respir Res Research BACKGROUND: Hyperoxia is shown to impair airway relaxation via limiting L-arginine bioavailability to nitric oxide synthase (NOS) and reducing NO production as a consequence. L-arginine can also be synthesized by L-citrulline recycling. The role of L-citrulline supplementation was investigated in the reversing of hyperoxia-induced impaired relaxation of rat tracheal smooth muscle (TSM). METHODS: Electrical field stimulation (EFS, 2–20 V)-induced relaxation was measured under in vitro conditions in preconstricted tracheal preparations obtained from 12 day old rat pups exposed to room air or hyperoxia (>95% oxygen) for 7 days supplemented with L-citrulline or saline (in vitro or in vivo). The role of the L-citrulline/L-arginine cycle under basal conditions was studied by incubation of preparations in the presence of argininosuccinate synthase (ASS) inhibitor [α-methyl-D, L-aspartate, 1 mM] or argininosuccinate lyase inhibitor (ASL) succinate (1 mM) and/or NOS inhibitor [N(ω)-nitro-L-arginine methyl ester; 100 μM] with respect to the presence or absence of L-citrulline (2 mM). RESULTS: Hyperoxia impaired the EFS-induced relaxation of TSM as compared to room air control (p < 0.001; 0.5 ± 0.1% at 2 V to 50.6 ± 5.7% at 20 V in hyperoxic group: 0.7 ± 0.2 at 2 V to 80.0 ± 5.6% at 20 V in room air group). Inhibition of ASS or ASL, and L-citrulline supplementation did not affect relaxation responses under basal conditions. However, inhibition of NOS significantly reduced relaxation responses (p < 0.001), which were restored to control level by L-citrulline. L-citrulline supplementation in vivo and in vitro also reversed the hyperoxia-impaired relaxation. The differences were significant (p <0.001; 0.8 ± 0.3% at 2 V to 47.1 ± 4.1% at 20 V without L-citrulline; 0.9 ± 0.3% at 2 V to 68.2 ± 4.8% at 20 V with L-citrulline). Inhibition of ASS or ASL prevented this effect of L-citrulline. CONCLUSION: The results indicate the presence of an L-citrulline/L-arginine cycle in the airways of rat pups. L-citrulline recycling does not play a major role under basal conditions in airways, but it has an important role under conditions of substrate limitations to NOS as a source of L-arginine, and L-citrulline supplementation reverses the impaired relaxation of airways under hyperoxic conditions. BioMed Central 2012 2012-08-07 /pmc/articles/PMC3487946/ /pubmed/22870905 http://dx.doi.org/10.1186/1465-9921-13-68 Text en Copyright ©2012 Sopi et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Sopi, Ramadan B Zaidi, Syed IA Mladenov, Mitko Sahiti, Hazbije Istrefi, Zahide Gjorgoski, Icko Lajçi, Azem Jakupaj, Muharrem L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia |
title | L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia |
title_full | L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia |
title_fullStr | L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia |
title_full_unstemmed | L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia |
title_short | L-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia |
title_sort | l-citrulline supplementation reverses the impaired airway relaxation in neonatal rats exposed to hyperoxia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487946/ https://www.ncbi.nlm.nih.gov/pubmed/22870905 http://dx.doi.org/10.1186/1465-9921-13-68 |
work_keys_str_mv | AT sopiramadanb lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia AT zaidisyedia lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia AT mladenovmitko lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia AT sahitihazbije lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia AT istrefizahide lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia AT gjorgoskiicko lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia AT lajciazem lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia AT jakupajmuharrem lcitrullinesupplementationreversestheimpairedairwayrelaxationinneonatalratsexposedtohyperoxia |